| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |